[Effects of lncRNA RP11-770J1.3 and TMEM25 expression on paclitaxel resistance in human breast cancer cells]

Zhejiang Da Xue Xue Bao Yi Xue Ban. 2017 Jul 25;46(4):364-370. doi: 10.3785/j.issn.1008-9292.2017.08.04.
[Article in Chinese]

Abstract

Objective: To investigate the effects of long non-coding RNA(lncRNA) RP11-770J1.3 and transmembrane protein 25 (TMEM25) on paclitaxel resistance in human breast cancer MCF-7/PR cell line.

Methods: The expression of lncRNA RP11-770J1.3 and TMEM25 in human breast cancer MCF-7(paclitaxel sensitive) and MCF-7/PR(paclitaxel resistant) cells were detected by quantitative RT-PCR. The synthetic interfering fragments of lncRNA RP11-770J1.3 and TMEM25 were transfected into MCF-7/PR cells. Sulforhodamine B assay was used to detect the sensitivity of MCF-7/PR cells to paclitaxel after interference of lncRNA RP11-770J1.3 and TMEM25. The expression of multidrug-resistance genes and proteins were detected by qRT-PCR and Western blot, respectively.

Results: lncRNA RP11-770J1.3 and TMEM25 were highly expressed in MCF-7/PR cells, and were significantly down-regulated after transfection of synthetic interfering fragments. Down-regulation of lncRNA RP11-770J1.3 and TMEM25 enhanced the sensitivity of MCF-7/PR cells to paclitaxel, and inhibited the expression of MRP, BCRP and MDR1/P-gp (all P<0.05). Such effects were more significant when lncRNA RP11-770J1.3 and TMEM25 were both down-regulated (all P<0.05).

Conclusions: lncRNA RP11-770J1.3 and TMEM25 are highly expressed in MCF-7/PR cells, and the down-regulation of lncRNA RP11-770J1.3 and TMEM25 can enhance paclitaxel sensitivity in MCF-7/PR cells.

目的: 探讨长链非编码RNA(lncRNA)RP11-770J1.3和跨膜蛋白25(TMEM25)对紫杉醇耐药人乳腺癌细胞株耐药性的影响。

方法: 利用实时定量PCR检测lncRNA RP11-770J1.3和TMEM25在人乳腺癌细胞MCF-7和紫杉醇耐药细胞株(MCF-7/PR)中的表达。在MCF-7/PR中转染lncRNA RP11-770J1.3和TMEM25的干扰片段,磺酰罗丹明B法检测MCF-7/PR对紫杉醇药物敏感性的变化,并运用实时定量PCR和蛋白质印迹法检测多药耐药相关蛋白(MRP)、乳腺癌耐药蛋白(BCRP)、多药耐药基因1(MDR1)及其编码产物P-gp mRNA和蛋白水平的改变。

结果: lncRNA RP11-770J1.3和TMEM25在MCF-7/PR中表达上调( P < 0.05或 P < 0.01)。与空白对照组和紫杉醇阴性对照组比较,干扰lncRNA RP11-770J1.3和TMEM25的表达可以提高MCF-7/PR对紫杉醇的药物敏感性,并下调耐药相关基因 MRPBCRPMDR1及其编码产物P-gp的表达(均 P < 0.05);与单独干扰lncRNA RP11-770J1.3或TMEM25比较,同时干扰lncRNA RP11-770J1.3和TMEM25的作用更加明显( P < 0.05)。

结论: MCF-7/PR中lncRNA RP11-770J1.3和TMEM25的表达上调,联合干扰lncRNA RP11-770J1.3和TMEM25的表达可以提高MCF-7/PR对紫杉醇的敏感性。

MeSH terms

  • Breast Neoplasms
  • Cell Line, Tumor
  • Drug Resistance, Neoplasm* / genetics
  • Gene Expression Regulation, Neoplastic*
  • Humans
  • MCF-7 Cells
  • Paclitaxel*
  • RNA, Long Noncoding* / genetics
  • RNA, Long Noncoding* / metabolism

Substances

  • RNA, Long Noncoding
  • Paclitaxel

Grants and funding

安徽省教育厅自然科学重大项目(KJ2015ZD29,KJ2016SD37);安徽省自然科学基金(1508085MH159);安徽省高校学科(专业)拔尖人才学术资助重点项目(gxbjZD2016069);安徽省蚌埠市科技计划项目(20150309);蚌埠医学院研究生创新项目(Byycxz1607,Byycx1607,Byycx1615)